Department of Cardiology, The Affiliated Hospital of Guilin Medical University, Guilin, Guangxi Province, China.
Department of Cardiology, The Second People's Hospital of Nanning City, The Third Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China.
Am J Physiol Heart Circ Physiol. 2020 Feb 1;318(2):H332-H344. doi: 10.1152/ajpheart.00444.2019. Epub 2019 Dec 20.
Increased production of reactive oxygen species (ROS) significantly contributed to the pathogenesis of acute myocardial infarction (AMI). Recent studies suggest that hypoxia upregulated the long noncoding RNA taurine upregulated gene 1 (TUG1). In this study, we explored the functional significance and molecular mechanisms of TUG1/miR-132-3p axis in ischemia-challenged cardiomyocytes. In primary cardiomyocytes challenged with HO, expressions of miR-132-3p, TUG1, and other target proteins were measured by RT quantitative PCR or Western blot analysis; cell viability by 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide assay; apoptosis by annexin V and propidium iodide staining; the abundance of acetylated H3K9 or histone deacetylase 3 (HDAC3) within the promoter of target genes by chromatin immunoprecipitation; the direct interaction between miR-132-3p and HDAC3 or TUG1 by luciferase reporter assay. The biological significance of miR-132-3p, TUG1, and HDAC3 was assessed using miR-132-3p mimic, siRNA-targeting TUG1 and HDAC3 inhibitor RGF966, respectively, in HO-challenged cells in vitro or ischemia-reperfusion (I/R)-induced AMI in vivo. miR-132-3p was downregulated, whereas TUG1 upregulated in HO-challenged cardiomyocytes. Overexpressing miR-132-3p or knocking down TUG1 significantly improved viability, inhibited apoptosis, and reduced ROS production in HO-stressed cardiomyocytes in vitro and alleviated I/R-induced AMI in vivo. Mechanistically, TUG1 sponged miR-132-3p and upregulated HDAC3, which reduced the acetylation of H3K9 and epigenetically inhibited expressions of antioxidative genes, including Bcl-xL, Prdx2, and Hsp70. The TUG1/miR-132-3p/HDAC3 axis critically regulates ROS production and the pathogenic development of AMI. Targeting TUG1, upregulating miR-132-3p, or inhibiting HDAC3 may benefit AMI treatment. Increased production of reactive oxygen species (ROS) significantly contributed to the pathogenesis of acute myocardial infarction (AMI). Recent studies suggest that hypoxia upregulated the long noncoding RNA taurine upregulated gene 1 (TUG1). However, the underlying mechanisms remain elusive. In the present study, we reported for the first time that HO or ischemia-reperfusion-induced TUG1, by sponging microRNA 132-3p, activated histone deacetylase 3, which in turn targeted multiple protective genes, stimulated intracellular ROS accumulation, and aggravated the injury of AMI. Our findings might provide some insight to seek new targets for AMI treatment.
活性氧(ROS)的产生增加是急性心肌梗死(AMI)发病机制的重要原因。最近的研究表明,缺氧上调了长链非编码 RNA 牛磺酸上调基因 1(TUG1)。在本研究中,我们探讨了 TUG1/miR-132-3p 轴在缺血性 challenged 心肌细胞中的功能意义和分子机制。在原代心肌细胞受到 HO 挑战时,通过 RT 定量 PCR 或 Western blot 分析测量 miR-132-3p、TUG1 和其他靶蛋白的表达;通过 3-(4,5-二甲基噻唑基-2)-2,5-二苯基四唑溴盐测定细胞活力;通过 Annexin V 和碘化丙啶染色测定细胞凋亡;通过染色质免疫沉淀测定靶基因启动子内乙酰化 H3K9 或组蛋白去乙酰化酶 3(HDAC3)的丰度;通过荧光素酶报告测定 miR-132-3p 与 HDAC3 或 TUG1 之间的直接相互作用。通过 miR-132-3p 模拟物、靶向 TUG1 的 siRNA 和 HDAC3 抑制剂 RGF966,分别在体外 HO 挑战细胞或体内缺血再灌注(I/R)诱导的 AMI 中评估 miR-132-3p、TUG1 和 HDAC3 的生物学意义。miR-132-3p 在 HO 挑战的心肌细胞中下调,而 TUG1 上调。在体外 HO 应激的心肌细胞中,过表达 miR-132-3p 或敲低 TUG1 可显著提高细胞活力,抑制细胞凋亡,减少 ROS 产生,并减轻体内 I/R 诱导的 AMI。在机制上,TUG1 海绵 miR-132-3p 并上调 HDAC3,这降低了 H3K9 的乙酰化,并通过表观遗传抑制抗氧化基因的表达,包括 Bcl-xL、Prdx2 和 Hsp70。TUG1/miR-132-3p/HDAC3 轴对 ROS 产生和 AMI 的发病机制具有重要调节作用。靶向 TUG1、上调 miR-132-3p 或抑制 HDAC3 可能有益于 AMI 的治疗。